{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:24:04Z","timestamp":1770679444931,"version":"3.49.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s12325-016-0336-3","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T06:03:10Z","timestamp":1461996190000},"page":"877-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanism-Oriented Therapy of Irritable Bowel Syndrome"],"prefix":"10.1007","volume":"33","author":[{"given":"Juan R.","family":"Malagelada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Malagelada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,30]]},"reference":[{"key":"336_CR1","doi-asserted-by":"publisher","unstructured":"Sperber AD, Dumitrascu D, Fukudo S, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut 2016. doi: 10.1136\/gutjnl-2015-311240 .","DOI":"10.1136\/gutjnl-2015-311240"},{"issue":"4","key":"336_CR2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004836-199912000-00009","volume":"29","author":"MW Russo","year":"1999","unstructured":"Russo MW, Gaynes BN, Drossman DA. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol. 1999;29(4):339\u201343.","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"336_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/2050640614554217","volume":"2","author":"TR Card","year":"2014","unstructured":"Card TR, Siffledeen J, Fleming KM. Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database. United Eur Gastroenterol J. 2014;2(6):505\u201312.","journal-title":"United Eur Gastroenterol J"},{"issue":"7","key":"336_CR4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/00365521.2013.786130","volume":"48","author":"TR Card","year":"2013","unstructured":"Card TR, Siffledeen J, West J, Fleming KM. An excess of prior irritable bowel syndrome diagnoses or treatments in celiac disease: evidence of diagnostic delay. Scand J Gastroenterol. 2013;48(7):801\u20137.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"336_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7861\/clinmedicine.9-2-131","volume":"9","author":"EM Quigley","year":"2009","unstructured":"Quigley EM, Shanahan F. The language of medicine: words as servants and scoundrels. Clin Med (Lond). 2009;9(2):131\u20135.","journal-title":"Clin Med (Lond)"},{"issue":"5","key":"336_CR6","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480\u201391.","journal-title":"Gastroenterology"},{"issue":"6","key":"336_CR7","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1572-0241.2003.07478.x","volume":"98","author":"L Chang","year":"2003","unstructured":"Chang L, Berman S, Mayer EA, et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol. 2003;98(6):1354\u201361.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"336_CR8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-131-11-199912070-00019","volume":"131","author":"SE Ross","year":"1999","unstructured":"Ross SE. \u201cMemes\u201d as infectious agents in psychosomatic illness. Ann Intern Med. 1999;131(11):867\u201371.","journal-title":"Ann Intern Med"},{"issue":"7","key":"336_CR9","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","volume":"122","author":"VS Chadwick","year":"2002","unstructured":"Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122(7):1778\u201383.","journal-title":"Gastroenterology"},{"issue":"2","key":"336_CR10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","volume":"104","author":"C Cremon","year":"2009","unstructured":"Cremon C, Gargano L, Morselli-Labate AM, , et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104(2):392\u2013400.","journal-title":"Am J Gastroenterol"},{"issue":"11\u201312","key":"336_CR11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/apt.12080","volume":"36","author":"J Matricon","year":"2012","unstructured":"Matricon J, Meleine M, Gelot A, et al. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012;36(11\u201312):1009\u201331.","journal-title":"Aliment Pharmacol Ther"},{"issue":"24","key":"336_CR12","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.3748\/wjg.v21.i24.7362","volume":"21","author":"D O\u2019Malley","year":"2015","unstructured":"O\u2019Malley D. Immunomodulation of enteric neural function in irritable bowel syndrome. World J Gastroenterol. 2015;21(24):7362\u20136.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"336_CR13","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3109\/00365521.2014.926982","volume":"49","author":"J Sundin","year":"2014","unstructured":"Sundin J, Rangel I, Kumawat AK, Hultgren-Hornquist E, Brummer RJ. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients. Scand J Gastroenterol. 2014;49(9):1068\u201375.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"336_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2006.11.039","volume":"132","author":"G Barbara","year":"2007","unstructured":"Barbara G, Wang B, Stanghellini V, et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132(1):26\u201337.","journal-title":"Gastroenterology"},{"issue":"8","key":"336_CR15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/gutjnl-2012-302093","volume":"62","author":"C Martinez","year":"2013","unstructured":"Martinez C, Lobo B, Pigrau M, et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 2013;62(8):1160\u20138.","journal-title":"Gut"},{"issue":"7","key":"336_CR16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/nmo.12358","volume":"26","author":"M Bashashati","year":"2014","unstructured":"Bashashati M, Rezaei N, Shafieyoun A, et al. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014;26(7):1036\u201348.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"336_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOG.0000000000000233","volume":"32","author":"S Cocciolillo","year":"2016","unstructured":"Cocciolillo S, Collins SM. The long-term functional consequences of acute infectious diarrhea. Curr Opin Gastroenterol. 2016;32(1):1\u20136.","journal-title":"Curr Opin Gastroenterol"},{"issue":"11","key":"336_CR18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.13199","volume":"41","author":"J Schwille-Kiuntke","year":"2015","unstructured":"Schwille-Kiuntke J, Mazurak N, Enck P. Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers\u2019 diarrhoea. Aliment Pharmacol Ther. 2015;41(11):1029\u201337.","journal-title":"Aliment Pharmacol Ther"},{"key":"336_CR19","doi-asserted-by":"publisher","unstructured":"Wouters MM, Van Wanrooy S, Nguyen A, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut 2015. doi: 10.1136\/gutjnl-2015-309460 .","DOI":"10.1136\/gutjnl-2015-309460"},{"issue":"3","key":"336_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/nmo.12497","volume":"27","author":"I Spreadbury","year":"2015","unstructured":"Spreadbury I, Ochoa-Cortes F, Ibeakanma C, Martin N, Hurlbut D, Vanner SJ. Concurrent psychological stress and infectious colitis is key to sustaining enhanced peripheral sensory signaling. Neurogastroenterol Motil. 2015;27(3):347\u201355.","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"336_CR21","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","volume":"95","author":"M Pimentel","year":"2000","unstructured":"Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95(12):3503\u20136.","journal-title":"Am J Gastroenterol"},{"key":"336_CR22","doi-asserted-by":"crossref","unstructured":"Di Stefano M, Corazza GR. The rationale for antibiotics in IBS. Am J Gastroenterol. 2008;103(10):2652.","DOI":"10.1111\/j.1572-0241.2008.02074_1.x"},{"issue":"4","key":"336_CR23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1572-0241.2008.01785.x","volume":"103","author":"JR Bratten","year":"2008","unstructured":"Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol. 2008;103(4):958\u201363.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"336_CR24","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/j.gastro.2014.01.050","volume":"146","author":"F Shanahan","year":"2014","unstructured":"Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology. 2014;146(6):1554\u201363.","journal-title":"Gastroenterology"},{"issue":"3","key":"336_CR25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/gut.2009.205476","volume":"60","author":"D Yu","year":"2011","unstructured":"Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60(3):334\u201340.","journal-title":"Gut"},{"issue":"5","key":"336_CR26","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/1574-6976.12075","volume":"38","author":"M Rajilic-Stojanovic","year":"2014","unstructured":"Rajilic-Stojanovic M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38(5):996\u20131004.","journal-title":"FEMS Microbiol Rev"},{"key":"336_CR27","doi-asserted-by":"publisher","unstructured":"Miquel S, Martin R, Lashermes A, et al. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Sci Rep. 2016;6. doi: 10.1038\/srep19399 .","DOI":"10.1038\/srep19399"},{"issue":"5S","key":"336_CR28","first-page":"A20","volume":"3","author":"A Wegner","year":"2015","unstructured":"Wegner A, Banaszkiewicz A, Kierkus J, et al. Effectiveness of Lactobacillus reuteri in the treatment of functional constipation in children: a randomized, double-blind, placebo-controlled, multicenter trial. United Eur Gastroenterol J. 2015;3(5S):A20.","journal-title":"United Eur Gastroenterol J"},{"key":"336_CR29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2148-10-36","volume":"10","author":"Y Itan","year":"2010","unstructured":"Itan Y, Jones BL, Ingram CJ, Swallow DM, Thomas MG. A worldwide correlation of lactase persistence phenotype and genotypes. BMC Evol Biol. 2010;10:36.","journal-title":"BMC Evol Biol"},{"issue":"7","key":"336_CR30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cgh.2010.03.027","volume":"8","author":"F Casellas","year":"2010","unstructured":"Casellas F, Aparici A, Casaus M, Rodriguez P, Malagelada JR. Subjective perception of lactose intolerance does not always indicate lactose malabsorption. Clin Gastroenterol Hepatol. 2010;8(7):581\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"336_CR31","doi-asserted-by":"crossref","unstructured":"Rumessen JJ, Gudmand-H\u00f8yer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986;27:1161\u20138.","DOI":"10.1136\/gut.27.10.1161"},{"issue":"1","key":"336_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10620-006-3100-8","volume":"51","author":"JL Madsen","year":"2006","unstructured":"Madsen JL, Linnet J, Rumessen JJ. Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci. 2006;51(1):147\u201353.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"336_CR33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2013.386","volume":"109","author":"K Murray","year":"2014","unstructured":"Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol. 2014;109(1):110\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"336_CR34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2014.07.046","volume":"147","author":"A Fritscher-Ravens","year":"2014","unstructured":"Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2014;147(5):1012\u201320.","journal-title":"Gastroenterology"},{"issue":"9","key":"336_CR35","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","volume":"61","author":"NA Koloski","year":"2012","unstructured":"Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain\u2013gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284\u201390.","journal-title":"Gut"},{"issue":"4","key":"336_CR36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1053\/j.gastro.2009.07.005","volume":"137","author":"S Buhner","year":"2009","unstructured":"Buhner S, Li Q, Vignali S, et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009;137(4):1425\u201334.","journal-title":"Gastroenterology"},{"issue":"6","key":"336_CR37","first-page":"2209","volume":"118","author":"JE Ghia","year":"2008","unstructured":"Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008;118(6):2209\u201318.","journal-title":"J Clin Invest"},{"key":"336_CR38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2014.09.002","volume":"51","author":"GC Dieleman","year":"2015","unstructured":"Dieleman GC, Huizink AC, Tulen JH, et al. Alterations in HPA-axis and autonomic nervous system functioning in childhood anxiety disorders point to a chronic stress hypothesis. Psychoneuroendocrinology. 2015;51:135\u201350.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"336_CR39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1073858408317242","volume":"14","author":"TD Perera","year":"2008","unstructured":"Perera TD, Park S, Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist. 2008;14(4):326\u201338.","journal-title":"Neuroscientist"},{"issue":"4","key":"336_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/nmo.12529","volume":"27","author":"SE Pritchard","year":"2015","unstructured":"Pritchard SE, Garsed KC, Hoad CL, et al. Effect of experimental stress on the small bowel and colon in healthy humans. Neurogastroenterol Motil. 2015;27(4):542\u20139.","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"336_CR41","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.cgh.2014.06.009","volume":"12","author":"DA Drossman","year":"2014","unstructured":"Drossman DA. Redux: do little bellyachers grow up to become big bellyachers? Clin Gastroenterol Hepatol. 2014;12(12):2033\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"336_CR42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrgastro.2014.32","volume":"11","author":"JR Walters","year":"2014","unstructured":"Walters JR. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol. 2014;11(7):426\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"336_CR43","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/ajg.2014.215","volume":"109","author":"M Camilleri","year":"2014","unstructured":"Camilleri M, Busciglio I, Acosta A, et al. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014;109(10):1621\u201330.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"336_CR44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gutjnl-2013-305965","volume":"64","author":"A Bajor","year":"2015","unstructured":"Bajor A, Tornblom H, Rudling M, Ung KA, Simren M. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut. 2015;64(1):84\u201392.","journal-title":"Gut"},{"issue":"9","key":"336_CR45","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cgh.2015.03.002","volume":"13","author":"I Aziz","year":"2015","unstructured":"Aziz I, Mumtaz S, Bholah H, Chowdhury FU, Sanders DS, Ford AC. High prevalence of idiopathic bile acid diarrhea among patients with diarrhea-predominant irritable bowel syndrome based on Rome III criteria. Clin Gastroenterol Hepatol. 2015;13(9):1650\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"336_CR46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1440-1746.2009.06149.x","volume":"25","author":"PR Gibson","year":"2010","unstructured":"Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010;25(2):252\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"336_CR47","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ajg.2013.96","volume":"108","author":"SJ Shepherd","year":"2013","unstructured":"Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108(5):707\u201317.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"336_CR48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/gutjnl-2015-309757","volume":"65","author":"GR De","year":"2016","unstructured":"De GR, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. 2016;65(1):169\u201378.","journal-title":"Gut"},{"issue":"1","key":"336_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","volume":"146","author":"EP Halmos","year":"2014","unstructured":"Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67\u201375.","journal-title":"Gastroenterology"},{"issue":"10","key":"336_CR50","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jada.2006.07.010","volume":"106","author":"SJ Shepherd","year":"2006","unstructured":"Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc. 2006;106(10):1631\u20139.","journal-title":"J Am Diet Assoc"},{"issue":"3","key":"336_CR51","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/apt.13041","volume":"41","author":"MC Lomer","year":"2015","unstructured":"Lomer MC. Review article: the aetiology, diagnosis, mechanisms and clinical evidence for food intolerance. Aliment Pharmacol Ther. 2015;41(3):262\u201375.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"336_CR52","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","volume":"149","author":"L Bohn","year":"2015","unstructured":"Bohn L, Storsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149(6):1399\u2013407.","journal-title":"Gastroenterology"},{"issue":"7","key":"336_CR53","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2006.00734.x","volume":"101","author":"PJ Whorwell","year":"2006","unstructured":"Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581\u201390.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"336_CR54","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1017\/S0007114515003347","volume":"114","author":"D Eskesen","year":"2015","unstructured":"Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Muller-Lissner S, Morberg CM. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12(R), on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015;114(10):1638\u201346.","journal-title":"Br J Nutr"},{"issue":"1","key":"336_CR55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/apt.12787","volume":"40","author":"G Sisson","year":"2014","unstructured":"Sisson G, Ayis S, Sherwood RA, Bjarnason I. Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome\u2013a 12\u00a0week double-blind study. Aliment Pharmacol Ther. 2014;40(1):51\u201362.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"336_CR56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jgh.12322","volume":"29","author":"JS Yoon","year":"2014","unstructured":"Yoon JS, Sohn W, Lee OY, et al. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol. 2014;29(1):52\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"336_CR57","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/00365521.2011.565066","volume":"46","author":"B Sondergaard","year":"2011","unstructured":"Sondergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol. 2011;46(6):663\u201372.","journal-title":"Scand J Gastroenterol"},{"key":"336_CR58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-230X-13-45","volume":"13","author":"LM Roberts","year":"2013","unstructured":"Roberts LM, McCahon D, Holder R, Wilson S, Hobbs FD. A randomised controlled trial of a probiotic \u2018functional food\u2019 in the management of irritable bowel syndrome. BMC Gastroenterol. 2013;13:45.","journal-title":"BMC Gastroenterol"},{"issue":"10","key":"336_CR59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.nut.2014.02.010","volume":"30","author":"C Stevenson","year":"2014","unstructured":"Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Nutrition. 2014;30(10):1151\u20137.","journal-title":"Nutrition"},{"issue":"3","key":"336_CR60","first-page":"127","volume":"57","author":"R Catanzaro","year":"2015","unstructured":"Catanzaro R, Anzalone M, Calabrese F, et al. The gut microbiota and its correlations with the central nervous system disorders. Panminerva Med. 2015;57(3):127\u201343.","journal-title":"Panminerva Med"},{"issue":"6","key":"336_CR61","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/j.gastro.2014.02.037","volume":"146","author":"EA Mayer","year":"2014","unstructured":"Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology. 2014;146(6):1500\u201312.","journal-title":"Gastroenterology"},{"issue":"38","key":"336_CR62","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108(38):16050\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"336_CR63","first-page":"1479","volume":"17","author":"JE Ghia","year":"2011","unstructured":"Ghia JE, Park AJ, Blennerhassett P, Khan WI, Collins SM. Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis. Inflamm Bowel Dis. 2011;17:1479\u201389.","journal-title":"Inflamm Bowel Dis"},{"issue":"5S","key":"336_CR64","first-page":"A53","volume":"3","author":"MI Pinto-Sanchez","year":"2015","unstructured":"Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Bifidobacterium longum NCC3001 improves depression and reduces brain emotional reactivity in patients with irritable bowel syndrome (IBS): a randomized, double blind, placebo-controlled trial. United Eur Gastroenterol J. 2015;3(5S):A53.","journal-title":"United Eur Gastroenterol J"},{"issue":"7","key":"336_CR65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pds.836","volume":"12","author":"C Huerta","year":"2003","unstructured":"Huerta C, Garcia Rodriguez LA, Wallander MA, Johansson S. Users of oral steroids are at a reduced risk of developing irritable bowel syndrome. Pharmacoepidemiol Drug Saf. 2003;12(7):583\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"336_CR66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.2003.01640.x","volume":"18","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Neal KR, et al. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18(1):77\u201384.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"336_CR67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gutjnl-2015-309122","volume":"65","author":"C Lam","year":"2016","unstructured":"Lam C, Tan W, Leighton M, et al. A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut. 2016;65(1):91\u20139.","journal-title":"Gut"},{"issue":"1","key":"336_CR68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","volume":"65","author":"G Barbara","year":"2016","unstructured":"Barbara G, Cremon C, Annese V, et al. Randomised controlled trial of mesalazine in IBS. Gut. 2016;65(1):82\u201390.","journal-title":"Gut"},{"key":"336_CR69","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","volume":"59","author":"TK Klooker","year":"2010","unstructured":"Klooker TK, Braak B, Koopman KE, et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut. 2010;59:1213\u201321.","journal-title":"Gut"},{"issue":"1","key":"336_CR70","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/gutjnl-2015-310024","volume":"65","author":"H Tornblom","year":"2016","unstructured":"Tornblom H, Simren M. In search for a disease-modifying treatment in irritable bowel syndrome. Gut. 2016;65(1):2\u20133.","journal-title":"Gut"},{"issue":"1","key":"336_CR71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","volume":"53","author":"J Yang","year":"2008","unstructured":"Yang J, Lee HR, Low K, Chatterjee S, Pimente M. Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci. 2008;53(1):169\u201374.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"336_CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ajg.2011.355","volume":"107","author":"SB Menees","year":"2012","unstructured":"Menees SB, Maneerattannaporn M, Kim HM, Chey WD. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107(1):28\u201335.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"336_CR73","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","volume":"44","author":"ZD Jiang","year":"2000","unstructured":"Jiang ZD, Ke S, Palazzini E, Riopel L, Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother. 2000;44(8):2205\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"336_CR74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.13437","volume":"43","author":"M Pimentel","year":"2016","unstructured":"Pimentel M. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2016;43(Suppl 1):37\u201349.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"336_CR75","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.gastro.2015.10.047","volume":"150","author":"S Fukudo","year":"2016","unstructured":"Fukudo S, Kinoshita Y, Okumura T, et al. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women. Gastroenterology. 2016;150(2):358\u201366.","journal-title":"Gastroenterology"},{"issue":"5","key":"336_CR76","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","volume":"167","author":"PR Wade","year":"2012","unstructured":"Wade PR, Palmer JM, McKenney S, et al. Modulation of gastrointestinal function by MuDelta, a mixed micro opioid receptor agonist\/micro opioid receptor antagonist. Br J Pharmacol. 2012;167(5):1111\u201325.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"336_CR77","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.13193","volume":"41","author":"F Fernandez-Banares","year":"2015","unstructured":"Fernandez-Banares F, Rosinach M, Piqueras M, et al. Randomised clinical trial: colestyramine vs. hydroxypropyl cellulose in patients with functional chronic watery diarrhoea. Aliment Pharmacol Ther. 2015;41(11):1132\u201340.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"336_CR78","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/apt.13065","volume":"41","author":"M Camilleri","year":"2015","unstructured":"Camilleri M, Acosta A, Busciglio I, , et al. Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2015;41(5):438\u201348.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0336-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:15:33Z","timestamp":1498306533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0336-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,30]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0336-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,30]]}}}